Mawson Infrastructure Group Inc. — Director's Dealing 2013

May 8, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OphthaliX, Inc. (OPLI)
CIK: 0001218683
Period of Report: 2013-04-22

Reporting Person: Singer Barak (Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-04-22	Options	$1.1757	A	469854	Acquired	2023-04-21	Common Stock (469854)	Direct
2013-04-22	Options	$1.1757	A	469854	Acquired	2023-04-21	Common Stock (469854)	Direct

Footnotes

F1: Options shall vest over a period of three years on a quarterly basis over twelve consecutive quarters from the date of commencement of the employment of Mr. Singer with the Company (February 28, 2013).

F2: Options shall vest upon the achievement of the following milestones by the Company (the "Success Based Options"): 156,618 options representing one third of the Success Based Options to vest upon the commencement of the trading of the Company's securities on Nasdaq or NYSE MKT LLC; 156,618 options representing the remaining third of the Success Based Options to vest upon the commencement of a phase 3 clinical trial of CF-101 for Glaucoma (and in the unlikely event that the phase 2 trial is unsuccessful, then the Board of Directors will allocate a different milestone).